Register
A new antibiotic for pneumonia and skin infections |
Journal Updates
eMediNexus Coverage from: 
A new antibiotic for pneumonia and skin infections
eMediNexus,  04 October 2018
remove_red_eye 592 Views
#Dermatology #Emergency Medicine #Pharmacist #Pulmonary Medicine

1 Read Comments                

The FDA approved omadacycline (Nuzyra) for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). Omadacycline is a semisynthetic derivative tetracycline antibiotic, specifically designed to overcome tetracycline resistance and proven to be effective across Gram-positive, Gram-negative, and other drug-resistant strains.
To continue reading this article
Or

Continue reading your article with a Emedinexus account..
Free Membership!